General MedicationsTOPICALGeneric
ERYTHROMYCIN
ERYTHROMYCIN
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 208154 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength GEL;TOPICAL - 2% Sponsor ENCUBE Submission history Latest submission status date: 2017-07-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 208154 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength GEL;TOPICAL - 2% Sponsor ENCUBE Submission history Latest submission status date: 2017-07-19 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.